By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    How Not to Become a Victim of Medical Scams
    How Not to Become a Victim of Medical Scams
    December 22, 2021
    11 Ways You Can Care for Your Elder Family Members Health
    11 Ways You Can Care for Your Elder Family Members Health
    April 6, 2022
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    How Can Brain Injury Lead To Dangerous Long-Term Effects?
    August 30, 2022
    Latest News
    The 6 Most Common Injuries Resulting from Motorcycle Accidents
    January 30, 2023
    6 Essential Strategies for Improving Your Medical Practice
    January 25, 2023
    Staying Positive While Living with Mesothelioma
    January 24, 2023
    The Many Health Benefits of Being Outdoors
    January 17, 2023
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    health benefits on Marijuana
    California Advocates Cite Health Benefits of Cannabis Legalization
    February 5, 2021
    Is It Right To Opt For A Home Care Service For Elderly Loved Ones?
    April 17, 2020
    Addressing Mental Health Problems in America’s Schools
    July 10, 2018
    Latest News
    Simplifying the Genetic Testing Process: How At-Home Kits are Changing the Game
    January 25, 2023
    9 Hospitals That Have Introduced Green Initiatives
    January 25, 2023
    Why a Health Retreat Can Be the Best Medicine
    January 12, 2023
    Best Money-Saving Tips for Health Managers
    January 12, 2023
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Will Covid Create Demand for Promising Biotech Startups?
Share
Sign In
Notification Show More
Latest News
investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care
prevent birth injuries
Distressing Birth Injuries and How They Can Be Prevented
Women Health
reduce infertility risks
Lifestyle Choices You Can Make to Minimize Infertility
Pregnancy
stablecoins in healthcare
Stablecoins May Change the Future of Healthcare Billing
News
Personal Injury Healing Tips and Strategies
Personal Injury Healing Tips and Strategies
Health
Aa
Health Works CollectiveHealth Works Collective
Aa
Search
Have an existing account? Sign In
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Covid-19 > Will Covid Create Demand for Promising Biotech Startups?
Covid-19

Will Covid Create Demand for Promising Biotech Startups?

Ryan Kh
Last updated: 2021/08/03 at 7:16 PM
Ryan Kh
Share
7 Min Read
biotech startups
Shutterstock Licensed Photo - By Nadia Snopek | stock vector ID: 1691828176
SHARE

The Covid-19 pandemic has upended most of the world. It is creating a lot of anxiety for people worried about getting sick and led to a number of challenges for companies in all sectors. However, not everyone has been adversely affected. Biotech companies are seeing a number of new promising opportunities after already working on great solutions to cancer.

Will this demand continue after the pandemic ends? It likely will, which is why there are so many great biotech penny stocks to watch.

Biotech Companies will Benefit from Covid-19 Hysteria for Years

The STAT 2020 summit, which brings together the best in medicine, technology and various world leaders in the fight against the COVID-19 pandemic, ended its third day with the exclusive participation of leading experts on policy, healthcare and other topics, where attendees were able to keep up to date with the most relevant news on this virus and the main trends in health and biotechnology. One of the conclusions from this conference is that biotechnology advances will be even more important to healthcare in the future as the pandemic starts to wane.

David Feinberg, director of Google Health, spoke about the work carried out by the search giant’s section designed to help millions of people in the pandemic and explained the active role of Internet users in finding out more about their ailments and how to seek medical attention. The division has over 500 employees and is growing.

More Read

Has the Pandemic Changed How Healthcare Providers Operate?

How the Pandemic Changed the Daily Role of Medical Office Assistants
10 useful healthcare apps for you during the COVID-19 pandemic
What You Need to Know About Health Standards for PCR Tests in Glasgow
What You Should Know About the Lateral Flow Test for COVID-19

He said that work conducted from Google Health is mainly done for hospitals to help them organize their huge amount of information from their patients’ medical records. When you go to a hospital, you generate a lot of very diverse electronic data that sometimes gets lost or is only available to one sector. There are even medical orders that are only written on paper. What Google Health does is standardize and concentrate all that information so that it is in a more correct form and available to every doctor who needs to follow up on a patient. It’s similar to the searches Google applies to other commercial clients, only it is focused on healthcare.

The goal is to save doctors and nurses time so they spend less time on the computer searching and more time with their patients. During the COVID-19 pandemic, Feinberg noticed the big trend in millions of people asking medical questions, especially whether they have coronavirus or not and then how Google can help them and connect them with health systems that cover the costs they generate.

Prior to holding this position at Google Feinberg worked in hospital administration. When asked by host Erin Brodwin what lessons he learned from his hospital work to then apply at Google, Feinberg replied, “Coming into Google I knew we had to be above and beyond the highest industry standards and above the information provided by others.”

Another specialist said that the biggest modern challenge is to have the highest level of transparency in the information and in the face of the large audience levels we generate to make sure they can see everything we do with the best security for them.

It was the turn of medicine. George Yancopoulos and Leonard S. Schleifer, co-founders of Regeneron Pharmaceuticals, cleared doubts about the monoclonal antibody treatment that Donald Trump pushed as “a cure” against coronavirus. “I want everyone to get the same treatment as me,” he said in a five-minute video he recorded on the White House lawn. With that video, Trump finished catapulting the U.S. drugmaker into the limelight. After it was turned into a star, Regeneron was studied in much more detail and immediately attracted medical attention.

REGN-COV2 is part of a class of biotechnology therapies known as monoclonal antibodies. Several companies are using this technology to create copies of human antibodies against the new coronavirus. But while it may have been Trump’s treatment of choice, the drug is an experimental treatment still in clinical trials. “We are hopeful that approval will be granted very soon and await a final decision,” said Schleifer, the company’s co-founder and CEO.

But how does it work? REGN-COV2 antibodies target the surface of the SARS-CoV-2 protein spike and neutralize its ability to infect healthy cells. According to Regeneron, blocking this interaction between the virus and the infected person’s cells stops the infectious process and helps reduce the high levels of viral load generally associated with increased severity of disease caused by the coronavirus.

“Our data suggest that there are people who are at higher risk and for whom the treatment will have more benefit; more importantly, we don’t need to, based on the data, just target the drug to those people from a benefit and safety standpoint because it really looks like the treatment is safe and we wouldn’t be putting patients at risk who wouldn’t benefit as much from it. So, the benefit-risk in these early stages seems to be very favorable for everyone and if we were to treat everyone on average it would probably benefit the entire population,” cautioned Yancopoulos, co-founder and chief scientific officer of Regeneron Pharmaceuticals.

TAGGED: biotech startups, covid-19

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Ryan Kh August 3, 2021
Share this Article
Facebook Twitter Copy Link Print
Share
By Ryan Kh
Follow:
Ryan Kh is an experienced blogger, digital content & social marketer. Founder of Catalyst For Business and contributor to search giants like Yahoo Finance, MSN. He is passionate about covering topics like big data, business intelligence, startups & entrepreneurship. Email: ryankh14@icloud.com
Previous Article A Medical Marijuana Patient’s Guide to Home Cultivation
Next Article RNA vaccines RNA Vaccine Revolution Creates Huge Opportunity for Biotech Investors

Stay Connected

1.5k Followers Like
4.5k Followers Follow
2.8k Followers Pin
136k Subscribers Subscribe

Latest News

investing in senior care
5 Reasons Why Investing in Senior Care Is a Wise Choice?
Senior Care January 30, 2023
prevent birth injuries
Distressing Birth Injuries and How They Can Be Prevented
Women Health January 30, 2023
reduce infertility risks
Lifestyle Choices You Can Make to Minimize Infertility
Pregnancy January 30, 2023
stablecoins in healthcare
Stablecoins May Change the Future of Healthcare Billing
News January 30, 2023

You Might also Like

what medical industry learnt from covid-19
Covid-19

Who Should Get the COVID-19 Antibody Test Panel?

November 24, 2022
field hospital
BusinessCovid-19Hospital Administration

A Guide To Building A Well-Designed Field Hospital During COVID-19

October 12, 2022
covid-19 symptoms to look out for
Covid-19News

The Most Serious Symptoms of COVID to Watch Out For

July 3, 2022
the pandemic has changed the future of healthcare
Global HealthcarePolicy & Law

How Healthcare Is Changing to Combat the Next Deadly Pandemic

May 27, 2022
//

We influence million of users and is the most authentic source of information on healthcare business and technology news.

Quick Links

  • About
  • Contact
  • Privacy
Subscribe

Subscribe to our newsletter to get our newest articles instantly!

Follow US

© 2008-2023 HealthWorks Collective. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?